Literature DB >> 20459997

Acute renal failure in the medical ICU still predictive of high mortality.

D V Friedericksen1, L Van der Merwe, T L Hattingh, D G Nel, M R Moosa.   

Abstract

BACKGROUND: We aimed to determine the outcome and certain predictors of outcome for acute renal failure (ARF) in the medical intensive care unit (ICU) at Tygerberg Hospital.
METHOD: We conducted a retrospective, single-centre cohort study over 12 months comprising all patients admitted to the medical ICU with all causes of renal failure or who developed renal failure following admission to the ICU.
RESULTS: Of 198 medical patients admitted to the ICU, ARF occurred in 46 (23.2%). The leading cause of ARF was acute tubular necrosis. The ICU mortality for ARF patients was 47.8%, compared with 17.5% in ICU patients without ARF. Acute haemodialysis was performed in only 17.3% of the 46 ARF patients. Using Cox proportional hazard regression, we found that mean duration of stay (p<0.001), acute physiology and chronic health evaluation II (Apache II) score (p<0.001), mechanical ventilation (p<0.01), dialysis (p<0.04) and multi-organ failure (p<0.05) affected survival time.
CONCLUSIONS: We found that ARF is still associated with a high mortality rate and longer duration of stay, higher Apache II score, and need for mechanical ventilation; dialysis and presence of multi-organ failure were indicators of a higher mortality rate.

Entities:  

Mesh:

Year:  2009        PMID: 20459997

Source DB:  PubMed          Journal:  S Afr Med J


  20 in total

Review 1.  Nephrology in Africa--not yet uhuru.

Authors:  Charles R Swanepoel; Nicola Wearne; Ikechi G Okpechi
Journal:  Nat Rev Nephrol       Date:  2013-08-20       Impact factor: 28.314

2.  Inducible pluripotent stem cell-derived mesenchymal stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury.

Authors:  Sheung-Fat Ko; Yen-Ta Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Pei-Hsun Sung; Ben-Chung Cheng; Tien-Hung Huang; Yi-Ling Chen; Yi-Chen Li; Hsueh-Wen Chang; Mel S Lee; Chih-Chao Yang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

3.  Inhibition of histone methyltransferase G9a effectively protected the kidney against ischemia-reperfusion injury.

Authors:  Peihsun Sung; Chihchao Yang; John Y Chiang; Chihhung Chen; Chiwen Luo; Honkan Yip
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

4.  Extendin-4 protects kidney from acute ischemia-reperfusion injury through upregulation of NRF2 signaling.

Authors:  Yen-Yi Zhen; Chih-Chao Yang; Chi-Chih Hung; Chia-Chang Lee; Chen-Chang Lee; Chien-Hsing Wu; Yen-Ta Chen; Wei-Yu Chen; Kuan-Hung Chen; Hon-Kan Yip; Sheung-Fat Ko
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

5.  Enhanced protection against renal ischemia-reperfusion injury with combined melatonin and exendin-4 in a rodent model.

Authors:  Yi-Chih Chang; Shu-Yuan Hsu; Chih-Chao Yang; Pei-Hsun Sung; Yi-Ling Chen; Tien-Hung Huang; Gour-Shenq Kao; Sheng-Yi Chen; Kuan-Hung Chen; Hsin-Ju Chiang; Hon-Kan Yip; Fan-Yen Lee
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-01

6.  Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.

Authors:  Yen-Ta Chen; Cheuk-Kwan Sun; Yu-Chun Lin; Li-Teh Chang; Yung-Lung Chen; Tzu-Hsien Tsai; Sheng-Ying Chung; Sarah Chua; Ying-Hsien Kao; Chia-Hong Yen; Pei-Lin Shao; Kuan-Cheng Chang; Steve Leu; Hon-Kan Yip
Journal:  J Transl Med       Date:  2011-05-05       Impact factor: 5.531

7.  Thyroid function status and its impact on clinical outcome in patients admitted to critical care.

Authors:  Faiza A Qari
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

8.  Understanding acute kidney injury in low resource settings: a step forward.

Authors:  Shuchi Anand; Dinna N Cruz; Fredric O Finkelstein
Journal:  BMC Nephrol       Date:  2015-01-16       Impact factor: 2.388

9.  Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.

Authors:  Yen-Ta Chen; Chih-Chau Yang; Yen-Yi Zhen; Christopher Glenn Wallace; Jenq-Lin Yang; Cheuk-Kwan Sun; Tzu-Hsien Tsai; Jiunn-Jye Sheu; Sarah Chua; Chia-Lo Chang; Chung-Lung Cho; Steve Leu; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2013-05-31       Impact factor: 6.832

10.  Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.

Authors:  Yen-Ta Chen; Tzu-Hsien Tsai; Chih-Chau Yang; Cheuk-Kwan Sun; Li-Teh Chang; Hung-Hwa Chen; Chia-Lo Chang; Pei-Hsun Sung; Yen-Yi Zhen; Steve Leu; Hsueh-Wen Chang; Yung-Lung Chen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2013-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.